Surgery To Scrap Those Specs

When noises roused Catherine Schmeltz in the middle of the night, she used to fumble for her glasses before checking on her kids. So when the 41-year-old Kansas City oncology nurse heard about a clinical trial for corneal implants to correct mild nearsightedness, she signed up. Today, her vision is 20/12.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.